- Report
- October 2024
- 181 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- January 2022
- 200 Pages
Global
From €7109EUR$7,500USD£5,939GBP
- Report
- January 2022
- 60 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1185EUR$1,250USD£990GBP
- Report
- January 2022
- 110 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- January 2022
- 40 Pages
Saudi Arabia
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 40 Pages
India
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 80 Pages
Africa
From €1896EUR$2,000USD£1,584GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 40 Pages
United States
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 40 Pages
South Korea
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 40 Pages
Russia
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 40 Pages
Ireland
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 40 Pages
Germany
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 40 Pages
France
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 40 Pages
Brazil
From €1422EUR$1,500USD£1,188GBP
- Report
- January 2022
- 40 Pages
China
From €1422EUR$1,500USD£1,188GBP

The Hepatorenal Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It focuses on drugs used to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including cirrhosis, hepatitis, nephrotic syndrome, and renal failure. They can also be used to reduce the risk of complications from liver and kidney diseases. Common drugs in this market include antivirals, immunosuppressants, diuretics, and antifibrotics.
The Hepatorenal Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in this market include AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck, and Pfizer. Other companies include AstraZeneca, Bayer, Novartis, and Sanofi. Show Less Read more